End of year statistics, 2025
In 2025 three important events were organized on three continents succesfully: The Cyclodextrin News blog published approx. 268 posts in 2024.
Special issue ‘Responsive nanoparticles in drug delivery systems’
The inclusion of a broad variety of nanomaterials inside drug delivery systems leads to the successful development of hybrid platforms
End of year statistics, 2025
In 2025 three important events were organized on three continents succesfully: The Cyclodextrin News blog published approx. 268 posts in 2024.
A supramolecular assembly made with sulfobutylether-β-cyclodextrin and magnetic Fe3O4 showing water remediation properties
In this paper, a magnetic hybrid system was produced by supramolecular self-assembly between low-cost precursors: the sulfobutylether-β-cyclodextrin (SBECD) and magnetic
Chiral Separation in Capillary Electrophoresis Using Cyclodextrins in Combination with Hydrophobic Deep Eutectic Solvents
Hydrophobic deep eutectic solvents (HDESs) can serve as pseudostationary phases (PSPs) in capillary electrophoresis (CE). Their integration into conventional chiral
Neuroprotective effects of statins and cyclodextrins: review and potential role in dementia treatment
Dementia is a progressive and irreversible deterioration in cognition that has a significant impact on the person’s activities of daily
Improve the scent of Christmas tree by CD-stabilized pine oil!
Standing artificial Christmas tree is getting more and more popular by improving the quality of these products which are nowadays
Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis
Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the
HPBCD and polysorbate containing formulation to eliminate aggregation of a potent osteogenic protein, recombinant human NELL-1
This study utilized a four-stage rational formulation development approach to mitigate aggregation and stabilize a high molecular weight protein, rhNELL-1.
Cyclodextrin-based carriers for targeted drug delivery, a new review
This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,
Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate
The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to